Hh-induced Smoothened conformational switch is mediated by differential phosphorylation at its C-terminal tail in a dose- and position-dependent manner  by Fan, Junkai et al.
Developmental Biology 366 (2012) 172–184Contents lists available at SciVerse ScienceDirectDevelopmental Biology0012-16
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/developmentalbiologyHh-induced Smoothened conformational switch is mediated by differential
phosphorylation at its C-terminal tail in a dose- and
position-dependent mannerJunkai Fan, Yajuan Liu, Jianhang Jia n
Markey Cancer Center, Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USAa r t i c l e i n f o
Article history:
Received 25 October 2011
Received in revised form
2 April 2012
Accepted 7 April 2012
Available online 19 April 2012
Keywords:
Smo
PKA
CK1
Phosphorylation
Hh
Signal transduction06/$ - see front matter & 2012 Elsevier Inc. A
x.doi.org/10.1016/j.ydbio.2012.04.007
esponding author. Fax: þ1 859 257 6030.
ail address: Jianhang.jia@uky.edu (J. Jia).a b s t r a c t
The activation of Smoothened (Smo) requires phosphorylation at three clusters of Serine residues in
Drosophila Hedgehog (Hh) signaling. However, the mechanism by which phosphorylation promotes
Smo conformational change and subsequently activates Smo in response to Hh gradient remains
unclear. Here, we show that the conformational states of Smo are determined by not only the amount
but also the position of the negative charges provided by phosphorylation. By using a Smo phospho-
speciﬁc antibody, we demonstrate that Smo is differentially phosphorylated at three clusters of serine
residues in response to levels of Hh activity. Mutating the ﬁrst cluster, compared to mutating the other
clusters, impairs Smo activity more severely, whereas mutating the last cluster prohibits C-terminus
dimerization. In addition, phosphorylation of the membrane proximal cluster promotes phosphoryla-
tion of the distal cluster. We propose a zipper-lock model in which the gradual phosphorylation at
these clusters induces a gradual conformational change in the Smo cytoplasmic tail, which promotes
the interaction between Smo and Costal2 (Cos2). Moreover, we show that Hh regulates both PKA and
CK1 phosphorylation of Smo. Thus, the differential phosphorylation of Smo mediates the thresholds of
Hh activity.
& 2012 Elsevier Inc. All rights reserved.Introduction
The Hedgehog (Hh) morphogen controls several key development
processes in a concentration-dependent manner (Ingham and
McMahon, 2001; Ingham et al., 2011; Jiang and Hui, 2008; Riddle
et al., 1993; Roelink et al., 1995). In Drosophila, Hh protein plays a
broad role in the development of appendages, such as wings, eyes,
and legs. One of the best systems for studying Hh signaling is the
wing imaginal disc, in which the posterior (P) compartment cells
express and secrete Hh proteins that act upon neighboring anterior
(A) compartment cells located adjacent to the A/P boundary to induce
the expression of decapentaplegic (dpp), which encodes a member of
the TGFb/BMP family of secreted proteins (Basler and Struhl, 1994;
Tabata and Kornberg, 1994). The Dpp protein then diffuses bidir-
ectionally into both the A and P compartments and functions as a
morphogen to control the growth and patterning of cells in the entire
wing in a concentration-dependent manner (Campbell and
Tomlinson, 1999; Lecuit et al., 1996; Nellen et al., 1996). Hh also
speciﬁes cell patterning at the A/P boundary by activating other
genes, including engrailed (en) and ptc (Strigini and Cohen, 1997;ll rights reserved.Vervoort et al., 1999). Low levels of Hh are able to induce the
expression of dpp, whereas higher levels of Hh are also able to
activate ptc. The induction of en appears to require the highest doses
of Hh signaling activities (Strigini and Cohen, 1997). Thus, Hh activity
levels can be monitored by expression of different responsive genes.
Based on these ﬁndings, it is important to understand how cells
perceive and transduce signal gradients, and how these gradients
induce differential cell fates.
The receptor complex of Hh signaling consists of Patched (Ptc) and
Ihog (Zheng et al., 2010). The seven-transmembrane protein Smooth-
ened (Smo) acts as a signal transducer, and its activity is inhibited by
Ptc in the absence of Hh (Hooper and Scott, 2005; Jia and Jiang, 2006;
Lum and Beachy, 2004). Binding of Hh to Ptc-Ihog relieves Smo from
Ptc inhibition, allowing Smo to activate the Cubitus interuptus (Ci)/Gli
family of Zn-ﬁnger transcription factors, which induces the expres-
sion of Hh target genes (Hooper and Scott, 2005; Jia and Jiang, 2006).
The presence of Hh promotes the cell surface accumulation and
phosphorylation of Smo (Denef et al., 2000) by protein kinase A (PKA),
casein kinase 1 (CK1) (Apionishev et al., 2005; Jia et al., 2004; Zhang
et al., 2004), casein kinase 2 (CK2) (Jia et al., 2010), and G protein-
coupled receptor kinase 2 (GRK2) (Chen et al., 2010) at the C-terminal
cytoplasmic tail (C-tail) of Smo. Phosphorylation promotes Smo
activation by inducing a conformational change in the protein (Zhao
et al., 2007), which most likely promotes the interaction between
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Lum et al., 2003; Ogden et al., 2003). In addition, the levels of Smo
activity are closely correlated with the levels of Smo phosphorylation
(Jia et al., 2004; Zhao et al., 2007). Among the kinases identiﬁed to
date, PKA and CK1 play an essential role in activating Smo by
phosphorylating Smo at three clusters of Serine residues in its C-tail
(Aikin et al., 2008; Zhao et al., 2007). One important question is how
phosphorylation of Smo at the three clusters contributes to its
activity. It has been shown that these phosphorylation events
counteract the autoinhibition imposed by adjacent clusters of argi-
nine residues (Zhao et al., 2007). Phosphorylation at individual
clusters neutralizes the adjacent arginine motifs and induces an open
conformation, which promotes Smo dimerization (Jiang and Hui,Fig. 1. Characterization of a Smo phospho-speciﬁc antibody (SmoP). (A) Smo sequence indic
red and CK1 sites in green. (B) Smo phosphorylation by PKA and CK1 is detected by the an
proteins and the commercial PKA and CK1 kinases. GST is used as a control. (C) S2 cells w
medium or control medium, in combination with H-89 and/or CK1–7 inhibitors. To norm
degradation, and samples were normalized for loading. All ﬁgures in this study show
immunoprecipitated with the anti-Myc antibody and blotted with either anti-Myc to detec
directly detect Smo phosphorylation. GFP served as a transfection and loading control. (D)
medium followed by immunoprecipitation with the anti-Myc antibody and western blot wi
Myc-Smowas normalized by themethod described above. (E–E0) A wing disc expressing Flag
antibodies. (F–F00) A large magniﬁcation of a wing disc expressing Flag-Smo under MS1096 G
The dash line indicates the A/P boundary that is marked by Ci staining. (G–H0) Wing discs e
and Flag. All wing imaginal discs shown in this study were oriented with anterior on the le2008). However, it is unclear how phosphorylation counteracts the
positive charges that are exerted by the arginine clusters.
In this study, by using a Smo phospho-speciﬁc antibody, we found
that Smo is differentially phosphorylated in response to different
levels of Hh signaling activity. We also found that in addition to the
number of phosphorylated sites, the position of the phosphorylated
residues is critical for establishing the stoichiometry of Smo activity.
A phospho-deﬁcient mutation at the ﬁrst cluster reduces Smo activity
more severely than mutation at the other clusters. In contrast, a
phosphomimetic mutation of the ﬁrst cluster induces Smo activity to
a higher level than a phosphomimetic mutation at the other
individual clusters. We further found that phosphorylation at the
ﬁrst cluster promotes the phosphorylation at the second cluster.ating the three phosphorylation clusters located in the C-tail, with PKA sites marked in
ti-SmoP antibody. An in vitro kinase assay is shown here using the puriﬁed GST-Smo
ere transfected with Myc-SmoWT or Myc-SmoSAS and treated with HhN-conditioned
alize the levels of Smo, 50 mM MG132 and 15mM NH4Cl was used to block Smo
ing the levels of Myc-Smo were normalized by this method. Cell extracts were
t Smo phosphorylation, indicated by its mobility shift on the SDS gel, or anti-SmoP, to
S2 cells were transfected with Myc-SmoWT and treated with OA or HhN-conditioned
th anti-Myc or anti-SmoP antibodies. GFP served as a transfection and loading control.
-SmoWT underMS1096 Gal4 control were immunostained with anti-SmoP and anti-Flag
al4. The arrow indicates SmoP staining in A compartment cells near the A/P boundary.
xpressing Flag-SmoWT with Hh or Flag-SmoSAS by MS1096-Gal4 were stained for SmoP
ft and ventral on the top.
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phorylation at adjacent sites, we provide evidence that phosphomi-
metic mutations at PKA sites do not constitutively promote CK1
phosphorylation, and that CK1 phosphorylation is regulated by Hh.
We propose a zipper-lock model in which phosphorylation at the
three clusters of serine residues promotes a gradual conformational
change to activate Smo.Fig. 2. Gradient of Hh signaling activity induces differential phosphorylation of Smo. (A
with 40 ng (Hhþ), 80 ng (Hhþþ), or 160 ng (Hhþþþ) of UAST-HhN and the indicated am
(C–C’) A time course experiment using S2 cells co-transfected with Myc-SmoWT and tub
two halves, one half for detection of Smo phosphorylation by western blot analysis usin
and the second half for the luciferase assay. Myc-Smo was normalized by the meth
accumulation by using the same treatments of S2 cells as used for C–C’. Cells were im
visualize cell surface Smo (top panel). Quantiﬁcation of cell surface and total Smo leve
indicate the percentage of Smo on the cell surface. The intensity of whole cell signal from
with the indicated construct and treated with different amounts of Hh-medium. The ce
the second for the luciferase assay. Myc-Smo was normalized by the method described
surface accumulation under different conditions. Quantiﬁcation is shown in the bottom
Smo on the cell surface. The intensity of whole cell signal from the highest Hh treatmResults
Generation and characterization of a Smo phospho-speciﬁc antibody
Hh signaling induces Smo C-tail phosphorylation at three
clusters of serine residues, including three typical PKA sites that
are each followed by two CK1 sites (Fig. 1A). Our understanding of–B) A ptc-luc reporter assay in S2 cells. S2 cells in 6-well plates were co-transfected
ount of either UAST-Ci or tub-Ci. The y-axis represents normalized ptc-luc activity.
-Ci and treated with 60% of Hh-medium in 6-well plates. Cells were then split into
g the Myc-IP followed by western blot with the anti-Myc or anti-SmoP antibodies,
od described above. (D) A time course experiment to examine Smo cell surface
munostained with the anti-SmoN antibody before membrane permeabilization to
ls is shown in the bottom panel (mean7SD; nZ20). The numbers below the bars
24 h treatment was set as 100. (E–E’) S2 cells in 6-well plates were co-transfected
lls were then split into two halves, one for detection of Smo phosphorylation, and
above. (F) A parallel experiment similar to that used in E–E’ to examine Smo cell
panel (mean7SD; nZ20). The numbers below the bars indicate the percentage of
ent was set as 100.
J. Fan et al. / Developmental Biology 366 (2012) 172–184 175Smo phosphorylation by PKA and CK1 kinases has been derived
mainly from a combination of in vitro kinase assays and in vivo
functional assays of phosphorylation sites mutations. The phos-
phorylation of individual sites in vivo and its regulation by
different levels of Hh activity has not been determined. As a ﬁrst
step toward addressing this important issue, we generated an
antibody to speciﬁcally detect phosphorylation at the 2nd cluster
(anti-SmoP). To characterize this antibody, we carried out an
in vitro kinase assay by using the commercial PKA/CK1 kinases
and glutathione S-transferase (GST)-Smo fusion proteins. GST-
Smo-PKA has an S4A mutation in the PKA site and GST-Smo-CK1
has S4A mutations in the two CK1 sites of the 2nd phosphoryla-
tion cluster. As shown in Fig. 1B, phosphorylation of GST-Smo by
PKA and CK1 was detected by the anti-SmoP antibody (Fig. 1B,
lane 2, top panel). Mutation in the PKA site in the 2nd cluster
abolished phosphorylation by PKA and CK1, as shown by the loss
of signal in the western blot using the anti-SmoP antibody (lane 3,
top panel). Mutations in CK1 sites blocked phosphorylation by
CK1 but did not affect the phosphorylation of the PKA site (lane 4,
top panel). The anti-SmoP antibody did not recognize the unpho-
sphorylated forms of Smo (lanes 5–6, top panel). These results
indicate that the phospho-speciﬁc SmoP antibody is able to detect
both PKA and CK1 phosphorylation within the 2nd cluster.
To determine whether the anti-SmoP antibody was able to
detect in vivo phosphorylation of Smo, we transfected S2 cells
with Myc-tagged full-length wild-type Smo (Myc-SmoWT) or
Myc-tagged Smo containing a mutation in the PKA site of the
second cluster to alanine (Myc-SmoSAS), and then treated the
transfected cells with HhN-conditioned medium with or without
the PKA inhibitor H-89 or CK1 inhibitor CK1-7 as previously
described (Jia et al., 2004). Hh consistently induced Smo phos-
phorylation, which was readily detected by the anti-SmoP anti-
body (Fig. 1C, lane 2, top panel). H-89 severely reduced the SmoP
signals, whereas CK1-7 had only a slight effect (Fig. 1C, lanes 3–4).
Myc-SmoSAS was not phosphorylated in either the presence or
absence of Hh (Fig. 1C, lanes 5–6). Treatment with the phospha-
tase inhibitor okadaic acid (OA) enhanced the SmoP signal
(Fig. 1D, lane 2, top panel). These data indicate that the anti-
SmoP antibody is able to detect Smo phosphorylation at PKA and
CK1 sites located within the second cluster in cultured S2 cells.
We also performed immunostaining with the anti-SmoP and
anti-Flag antibodies in wing imaginal discs expressing Flag-
tagged wild-type Smo (Flag-SmoWT). We found that there was a
strong signal for the anti-SmoP antibody in P compartment cells
where Hh was present, but a very low signal in A compartment
cells that were located away from the A/P boundary where Hh
was not present (Fig. 1E). In addition, Hh induced a SmoP staining
gradient in A compartment cells near the A/P boundary (arrow in
Fig. 1F). Moreover, the coexpression of Hh induced a strong anti-
SmoP antibody signal in A compartment cells (Fig. 1G).
In contrast, there was no signal detected by the anti-SmoP
antibody when SmoSAS was expressed (Fig. 1H). These data
indicate that the anti-SmoP antibody is able to detect Hh-induced
phosphorylation of Smo in wing discs.
The Hh activity gradient induces differential phosphorylation and cell
surface accumulation of Smo
It has been postulated that different levels of Hh signaling
activity can induce different levels of Smo phosphorylation (Jia
et al., 2004; Zhao et al., 2007). However, a direct link between the
Hh signaling activity and the phosphorylation of Smo has not been
shown. To address this issue, we ﬁrst established a ptc-luciferase
(ptc-luc) reporter assay to monitor the activity of Hh signaling. As
shown in Fig. 2A, the increasing expression UAST-HA-Ci by ub-Gal4
induced increasingly higher level of ptc-luc reporter activity(Fig. 2A, compare the ﬁrst column in groups 1–5). The coexpres-
sion of increasing amounts of UAST-HhN induced ptc-luc reporter
activity in a dose-dependent manner, suggesting a response of S2
cells to Hh activity in the presence of transfected Ci. Therefore, we
next assessed whether the expression of Ci at the endogenous
level would work better under this situation in order to examine
the responsiveness to Hh. We generated a tub-Ci construct where
the UAS binding sites in pUAST were replaced by the tubulina
promoter to drive ci expression at a level close to that of the
endogenous gene expression (Basler and Struhl, 1994; Jia et al.,
2010). We found that the expression of Ci by the tubulina
promoter was able to mediate differential Hh activity, as assessed
by ptc-luc reporter activity (Fig. 2B). We normalized tub-Ci condi-
tions in this assay and chose the best responsive condition as a
standard for subsequent experiments (Fig. 2B, group 4).
We then assessed the correlation of Hh signaling activity to the
levels of Smo phosphorylation by using the anti-SmoP antibody.
S2 cells were co-transfected with Myc-SmoWT and tub-Ci followed
by treatment with HhN-conditioned medium. As shown in Fig. 2C,
after collecting the cells at different time points, we found that Hh
induced a higher level of Smo phosphorylation when the cells
were exposed to Hh for a longer period of time. The Hh activity
was monitored by ptc-luc reporter activity (Fig. 2C0). The assess-
ment of cell surface accumulation has been successfully used to
examine Smo activation in our previous studies, and therefore we
performed the same set of experiments to monitor the cell surface
accumulation of Smo. We found that Hh induced the cell surface
accumulation of Smo in a time-dependent manner (Fig. 2D),
suggesting a close correlation between phosphorylation and cell
surface accumulation. In a parallel experiment, we examined Smo
phosphorylation and cell surface accumulation when the cells
were treated with different amounts of Hh. As shown in Fig. 2E,
different levels of Hh activity induced different levels of Smo
phosphorylation, as indicated by the strength of the anti-SmoP
antibody signal (Fig. 2E, top panel). The gradient Hh activity was
monitored by ptc-luc reporter activity (Fig. 2E0). We further found
that Hh induced the cell surface accumulation of Smo in a dose-
dependent manner (Fig. 2F). Taken together, by combining the
luciferase and cell surface staining assays with a phosphorylation
assay using an anti-SmoP antibody, we were able to precisely
correlate the levels of phosphorylation and cell surface accumula-
tion of Smo to the levels of Hh signaling activity.
Substitution of the phosphorylation clusters does not change the
activity of Smo
To explore the contribution of phosphorylation at the three
clusters to Smo activity, we substituted the 1st cluster and 3rd
cluster with the 2nd cluster to create Smo222 (Fig. 3A). We then
generated transgenes using the PhiC31 integration system to
integrate Myc-tagged Smo222 (Myc-Smo222) or Smo222 in combi-
nation with the tubulina promoter (tub-Smo222) into the 75B1
attP locus in the ﬂy genome in order to examine the precise
activity of Smo222 (Bischof et al., 2007; Jia et al., 2010).
The expression of ptc and en were blocked in smo mutant cells
of wing imaginal discs (arrows in Fig. 3B and C). We found that
the expression of Myc-Smo222 under control of MS1096 Gal4 or
Smo222 under the tubulina promoter fully rescued ptc and en
expression in smo mutant cells (arrows in Fig. 3D–G), similar to
the rescue of SmoWT driven by the tubulina promoter or by
MS1096 Gal4 (Jia et al., 2010, 2003). In addition, overexpression
of Myc-Smo222 induced a comparable level of ectopic dpp-lacZ
expression (Fig. 3I) similar to that of Myc-SmoWT (Fig. 3H). The
anti-SmoP antibody was not able to detect the phosphorylation
of endogenous Smo in wing discs. However, there was a clear
increase in afﬁnity of the anti-SmoP antibody for Smo222,
Fig. 3. Changing the sequence of the phosphorylation clusters has no effect on Smo activity and responsiveness to Hh. (A) Sequence alignment of SmoWT and Smo222 in
which the 1st and 3rd clusters were substituted with the 2nd cluster. (B and C) Wing discs carrying smo mutant clones immunostained for Ptc (red), En (red), or GFP
(green). The smo mutant clones were recognized by the lack of GFP expression and the A/P boundaries were determined by Ci staining (not shown). (D–G) Wing discs
containing smo mutant clones and expressing either Myc-Smo222 by MS1096 Gal4 or Smo222 by the tubulina promoter were immunostained to show Ptc, En, and GFP.
The arrows indicate the rescued ptc or en expression by expressing Smo222 in smo cells. (H and I) Wing discs expressing Myc-SmoWT or Myc-Smo222 by MS1096 Gal4 were
stained for dpp-lacZ expression. The arrows indicate the comparable dpp-lacZ expression when either forms of Smo are expressed. (J) A wing discs expressing Smo222 by the
tubulina promoter is stained for SmoP and SmoN. (K) A large magniﬁcation image of the P compartment in the wing disc from Figure J. The arrowheads indicate the co-
localization of SmoP and SmoN on the cell membrane. (L and M) Large magniﬁcation images of the cells in P compartment of the wing discs expressing either Myc-SmoWT
or Myc-Smo222. The arrowheads indicate the co-localization of Myc and SmoP signals. (N) S2 cells were transfected with Myc-Smo222 and treated with Hh-medium in
combination with H-89 or CK1–7. Cell lysates were subjected to immunoprecipitation with anti-Myc followed by a western blot with anti-Myc or anti-SmoP antibodies.
GFP served as a transfection and loading control. Myc-Smo was normalized by the method described above. (O and P) Wing discs expressing SmoWT or Smo222 by the
tubulina promoter, or co-expressing SmoWT or Smo222 by the tubulina promoter along with UAS-Hh by MS1096 Gal4 were collected from ﬂies cultured at either 25 1C or
19 1C, and then subjected to direct western blot with the anti-SmoP antibody to detect the phosphorylated forms of SmoWT or Smo222, or with anti-Flag antibody to detect
the total Smo. The ratio of phosphorylated Smo to total Smo is shown in the right panel (each data set was from three repeats).
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ment cells (Fig. 3J) as well as A compartment cells near the A/P
boundary (not shown). These results indicated that Hh-induced
tub-Smo222 phosphorylation can be detected in vivo. Furthermore,
the anti-SmoP signal was mostly present at the plasma mem-
brane of P compartment cells, and the anti-SmoP signal co-
localized very well with the signal from the anti-SmoN antibody,
which recognizes the N-terminal extracellular domain of Smo
(arrowheads in Fig. 3K). Moreover, the anti-SmoP signal co-
localized with the anti-Myc signal in P compartment cells
expressing either Myc-SmoWT or Myc-Smo222 under control of
MS1096 Gal4 (arrowheads in Fig. 3L and M). These data indicate
that Smo222 functions similarly to SmoWT.
We next examined the phosphorylation of Smo222 in both
cultured S2 cells and wing discs by western blot. As shown in
Fig. 3N, Hh-induced Smo222 phosphorylation was detectable by
the anti-SmoP antibody and was diminished by treatment with
H-89 (Fig. 3N, lane 3, top panel), but attenuated by treatment
with CK1-7 (Fig. 3N, lane 4, top panel). To examine whether
different levels of Hh activity induce different levels of Smo
phosphorylation in wing discs, we expressed either tub-SmoWT
or tub-Smo222 together with UAS-Hh driven by MS1096 Gal4 in
wing discs at different temperatures. We found that a higher level
of Hh expression at a higher temperature induced a higher
phosphorylation level of both SmoWT and Smo222 compared to
lower Hh expression at a lower temperature (Fig. 3O and P). Smo
phosphorylation in the absence of UAS-Hh indicated that Smo
phosphorylation occurred in P compartment cells where endo-
genous Hh was expressed (lane 1 in Fig. 3O and P, top panel). The
use of the tubulina promoter ensured equal levels of Smo expres-
sion (Fig. 3O and P, lower panel). These data provide another
direct detection of in vivo Smo phosphorylation, which is regu-
lated by the Hh threshold. Similarly, the substitution of the 1st
cluster with the 2nd cluster (Smo223) fully rescued the smo
mutant, had comparable activity as Smo222 in the ability to induce
ectopic dpp-lacZ expression, and exhibited a similar phosphoryla-
tion pattern to that of Smo222 (data not shown). Taken together,
our results indicate that substitution among the three clusters did
not changed Smo activity or affect its responsiveness to Hh
stimulation.
Phosphorylation at 3 clusters does not equally contribute
to Smo activity
To investigate how phosphorylation regulates Smo activity, we
constructed a series of Smo mutants with different combinations
of PKA and CK1 site mutations (Figs. 4A, 5A). To ensure that Smo
was expressed at the same level without positional effects, we
generated all of the transgenes at the 75B1 attP locus. Expression
of SmoWT induced a low level of ectopic dpp-lacZ expression
(Fig. 4B) (Jia et al., 2003), whereas expression of SmoDDD (pre-
viously named SmoSD123) induced full dpp-lacZ expression in A
compartment cells (Fig. 4C) (Jia et al., 2004). Phosphomimetic
mutations of each cluster (SmoDSS, SmoSDS, SmoSSD; Fig. 4A)
elevated Smo activity, as evidenced by the higher level of ectopic
dpp-lacZ expression (Fig. 4D–F). A careful comparison indicated
that SmoDSS had a higher level of ectopic dpp-lacZ expression
compared to either SmoSDS or SmoSSD (Fig. 4D compared to Fig. 4E
and F). We further generated combinations of two cluster phos-
phomimetic mutations. Consistent with our previous ﬁndings,
SmoDDS (previously named SmoSD12) induced a further increase of
dpp-lacZ expression (Fig. 4G) (Jia et al., 2004). SmoDSD induced
ectopic dpp-lacZ expression at a level that was lower than that
induced by SmoDDS (Fig. 4H). Interestingly, SmoSDD was unable to
induce a further increase in dpp-lacZ expression (compared to
SmoDSS, SmoSDS, or SmoSSD), even though two of the three clusterswere mutated to aspartate (Fig. 4I). These results suggested that
sequential phosphorylation at the ﬁrst two clusters is critical for
Smo activation and that the position of phosphorylation plays a
role in activating Smo. We then generated SmoADD, SmoDAD, and
SmoDDA mutations (Fig. 4A). Surprisingly, the activity of SmoDDA
was dramatically impaired by an S4A mutation at the 3rd cluster
(Fig. 4L compared to 4G). SmoADD, SmoDAD, and SmoDDA induced a
low level of dpp-lacZ expression, which was comparable to SmoWT
(Fig. 4J–L). In addition, the expression of SmoADD, SmoDAD, and
SmoDDA at a higher temperature (30 1C) did not elevate their
activity (Fig. 4A), indicating that S4A mutations severely inter-
fered with the activity of Smo phosphomimetic mutants. How-
ever, SmoDDA restored dpp-lacZ expression and partially rescued
ptc expression, but did not rescue en expression in smo mutant
cells near the A/P boundary, suggesting that it could transduce
low, but not high, levels of Hh activity (Fig. 4A, data not shown).
The changes in Smo activity induced by these mutations were
conﬁrmed by the ptc-luc reporter assay (Fig. 4R).
We next assessed the activation of these mutants by measur-
ing Smo cell surface accumulation. We found that SmoADD,
SmoDAD, and SmoDDA exhibited a very low accumulation at the
cell surface (Fig. 4S, columns 9–11), which provided an explana-
tion of the inactivity in the wing discs. The cell surface accumula-
tion of the other Smo variants was consistent with their
individual activity in the imaginal discs (Fig. 4S).
Hh induces Smo dimerization at its C-terminal tail (Zhao et al.,
2007). Our ﬁnding that the in vivo activity and the cell surface
accumulation of SmoDDA were severely impaired by the S4A
mutation at the 3rd cluster prompted us to examine whether this
mutation blocks C-terminal dimerization. Therefore, we used the
ﬂuorescence resonance energy transfer (FRET) assay to test
C-terminal CFP/YFP dimerization. Consistent with the ﬁndings of
Zhao and colleagues (Zhao et al., 2007), SmoDDD had a very high
FRET signal compared to SmoWT (Fig. 4T, columns 1–2).
We further found that SmoDDA had much lower FRET signal and
was much less responsiveness to Hh stimulation compared to
SmoDDS (Fig. 4T), suggesting that the phospho-deﬁcient mutation
at the 3rd cluster blocks the dimerization of Smo at the C-tail.
Other Smo mutations exhibited different levels of FRET signal,
which was consistent with their in vivo activity (Fig. 4T and S1).
We next examined the dominant-negative activity of Smo
mutants that possessed two clusters of S4A mutations
(Fig. 5A). We found that SmoAAD, SmoAAS, and SmoSAA have
dominant negative activity, as indicated by their ability to block
ptc-lacZ and en expression in A compartment cells near the A/P
boundary (Fig. 5B and C, H and I, L and M). Consistent with this
ﬁnding, tub-SmoAAS and tub-SmoSAA did not rescue ptc and en
expression in smo null mutant cells (Fig. 5P and S). We also
found that SmoAAS had stronger dominant-negative activity than
SmoSAA, since SmoAAS blocked en expression in the wing disc more
severely than SmoSAA (Fig. 5I) and caused further fusion between
vein 3 and vein 4 (Fig. S2C), which is indicative of loss of Hh
signaling in the wings (Liu et al., 2007). Interestingly, we found
that overexpression of Myc-SmoADA, SmoDAA, and SmoASA did not
cause any dominant-negative effects in wing discs, which was
likely due to the split of the mutation sites or the ability of the
S4D mutations to counteract the S4A mutations (Figs. 5D–G,
and J and K). We further evaluated our ﬁndings by using the
ptc-luc reporter and FRET assays. As shown in Fig. 5T, expression
of SmoADA SmoDAA, and SmoASA did not induce ptc-luc activity.
Expression of SmoAAD, SmoAAS, or SmoSAA exhibited lower ptc-luc
activity compared to control, indicating their dominant-negative
activity in this assay (Fig. 5T, columns 3, 6, 8, and 9). In addition,
these mutations were barely responsive to Hh in terms of the
levels of FRET signal (Fig. 5U). Consistent with our previous
ﬁndings, mutation in one PKA site (SmoASS, SmoSAS, and SmoSSA),
Fig. 4. Intra-molecular mutations contribute differently to Smo activity. (A) A schematic drawing of Smo variants and their in vivo activity. In the sequence, enlarged black
Ser residues are the PKA sites and enlarged grey Ser residues are CK1 sites. Individual constructs were assayed for Hh signaling activity by overexpression under the
MS1096 Gal4 driver. Ectopic activity was scored by activated dpp-lacZ expression. Rescue experiments were carried out to examine whether expressing the indicated
constructs byMS1096-Gal4 can restore Hh target gene expression in smomutant cells. (B–O) Examples of the ability of each individual construct to induce ectopic dpp-lacZ
expression in wing discs, when driven by MS1096 Gal4. Of note, the activity of SmoDDA is dramatically reduced (L) compared to SmoDDS (G), and the activity of
SmoAPKADDCK1 is comparable to SmoDDD by inducing similar ectopic dpp-lacZ expression (compare M with C). (P–Q0) Wing discs expressing SmoDDD or SmoAPKADDCK1 were
stained for Ptc-lacZ (P and Q) and En (P0 and Q0). (R) The activity of each individual construct was assayed by the ptc-luc reporter in S2 cells using the method described
above. (S) The cell surface accumulation of each individual construct was measured with anti-SmoN antibody staining by using the method described above. Please note
that the cell surface accumulation of SmoDDA is dramatically reduced compared to SmoDDS. (T) FRET efﬁciency from the indicated WT or mutant Smo with CFP or YFP
tagged to their C-termini. SmoDDA, SmoDAD, and SmoADD have signiﬁcantly reduced FRET values, and are much less responsive to Hh.
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Fig. 5. Dominant-negative activity of Smo with phospho-deﬁcient mutations at different combination of clusters. (A) A schematic drawing of Smo mutants tested in this
ﬁgure. (B–O) Examples of dominant-negative activity of the indicated Smo constructs when driven by ap-Gal4 in wing discs. Arrowheads in B, H, L, and N indicate the
constrained ptc-lacZ expression in A compartment cells near the A/P boundary. Arrows in C, I, M, and O indicate the attenuated/blockade of en expression in A
compartment cells near the A/P boundary. The impaired ptc-pacZ and en expression suggest the dominant-negative activity of each individual Smo construct. (P–S) Wing
discs containing smo mutant clones and expressing SmoAAS or SmoSAA from the tubulina promoter were immunostained to show Ptc, En, and GFP. The smo mutant clones
are recognized by the lack of GFP expression. The arrows indicate that SmoAAS and SmoSAA do not rescue ptc or en expression in cells lacking endogenous smo. (T) The
ptc-luc reporter activity of the indicated Smo constructs that were expressed in S2 cells. (U) FRET efﬁciency from S2 cells transfected with the indicated Smo constructs and
treated with Hh-medium or control medium. Mutations at any of the two clusters interfere with their responsiveness to Hh.
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not change Smo activity, since the expression of these mutants by
the tubulina promoter fully rescued smo null phenotypes and the
overexpression of Myc-tagged mutants caused a similar low level
induction of ectopic dpp-lacZ expression (data not shown). In
contrast, mutations in all three PKA sites (SmoAAA, previously named
Smo-PKA123) caused Smo to have complete dominant-negative activ-
ity, since it extensively blocked ptc-lacZ and en expression (Fig. 5N
and O), severely reduced ptc-luc activity (Fig. 5T, column 9), and had
an extremely low FRET signal (Fig. 5U, column 8). Taken together,
our date suggest a model where phosphorylation promotes Smo
activation in a position-dependent manner.Fig. 6. Phosphorylation at one cluster promotes the phosphorylation at the nearby di
treated with Hh-medium. Cell extracts were immunoprecipitated with anti-Myc antib
served as a transfection and loading control. Myc-Smo was normalized by the method d
also subjected to luciferase assay in S2 cells with co-transfection of tub-Ci and the treat
expressing the indicated Smo constructs by MS1096 Gal4 were stained for SmoP. (F) S2
conditioned medium or control medium. Immunoprecipitation was carried out with the
antibody was used to detect phosphorylation of the 2nd cluster sequence. GFP served
described above. (G) S2 cells transfected with Myc-Smo222DSS or Myc-Smo222ASS were tr
and a western blot was performed with the indicated antibodies. GFP served as
described above.Phosphorylation of membrane proximal cluster promotes
phosphorylation of distal cluster
In this study, we found that the adjacent phosphorylation of
the ﬁrst two clusters is critical for Smo activation (Fig. 4). There-
fore, we contemplated whether phosphorylation at the 1st cluster
facilitated phosphorylation at the other clusters. To assess this
possibility, we transfected S2 cells with the Smo construct,
treated the cells with HhN-conditioned medium, and then exam-
ined Smo phosphorylation status using the anti-SmoP antibody.
Hh induced Smo phosphorylation was detected by the signal from
the anti-SmoP antibody (Fig. 6A, lane 1, top panel). Mutation ofstal cluster. (A) S2 cells were transfected with the indicated Smo constructs and
ody followed by western blot with either anti-SmoP or anti-Myc antibodies. GFP
escribed above. The bottom panel shows that the same set of Smo constructs were
ment of Hh-medium. The luciferase value of SmoASS was set as 1. (B–E) Wing discs
cells were transfected with the indicated Smo constructs and treated with HhN-
anti-Myc antibody. To detect phosphorylation at a speciﬁc position, the anti-SmoP
as a transfection and loading control. Myc-Smo was normalized by the method
eated with Hh-medium or control medium. Cell extracts were immunoprecipitated
a transfection and loading control. Myc-Smo was normalized by the method
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phosphorylation at the 2nd cluster, as indicated by the reduction
of anti-SmoP signal (lane 2, top panel). Phospho-deﬁcient muta-
tion at the 3rd cluster did not inﬂuence phosphorylation at the
2nd cluster (lane 3, top panel). In contrast, a phosphomimetic
mutation in the 1st cluster promoted phosphorylation at the 2nd
cluster (lane 4 and 6, top panel). Moreover, a phosphomimetic
mutation at the 3rd cluster did not promote phosphorylation at
the 2nd cluster (lane 5, top panel). The phosphorylation of Smo
variants was consistent with their activity in luciferase assays
(Fig. 6A, bottom panel).
We further examined whether Smo phosphorylation at the
second cluster of PKA/CK1 sites is affected by phosphorylation at
other clusters in wing discs. As shown in Fig. 6B, Myc-SmoWT was
phosphorylated in P compartment cells as well as A compartment
cells near the A/P boundary, a similar pattern to that of Flag-Smo
(Fig. 1E) but a much weaker anti-SmoP staining due to a lower
level expression of the protein at the VK5 locus (Venken et al.,
2006). Phospho-deﬁcient mutation at the ﬁrst PKA/CK1 cluster
(Myc-SmoASS) severely decreased phosphorylation at the second
PKA/CK1 cluster (Fig. 6C), whereas phosphomimetic mutation at
the ﬁrst cluster (Myc-SmoDSS) increased the phosphorylation at
the second cluster (Fig. 6D). In contrast, phosphomimetic muta-
tion at the third cluster (Myc-SmoSSD) had no effect on the
phosphorylation of the second cluster (Fig. 6E). A comparable
level of Smo expression was ensured by expression Smo at a
speciﬁc genomic locus and monitored by staining with the anti-
Myc antibody (not shown). These data consistently demonstrate
that phosphorylation at the ﬁrst PKA/CK1 cluster promotes
phosphorylation at the second cluster.
To further demonstrate that phosphorylation at one cluster
can promote phosphorylation at the distal cluster, we used the
anti-SmoP antibody to assess the phosphorylation of Smo muta-
tions. Smo1S2A2S and Smo1S2D2S were created by mutating the 2nd
cluster PKA and CK1 sites to either alanine or aspartate and
substituting the 3rd cluster with the 2nd cluster (Fig. 6F, sequence
alignment). Similarly, Smo2S2A3S and Smo2S2D3S had the 1st cluster
substituted with the 2nd cluster and the 2nd cluster PKA and CK1
sites mutated to either alanine or aspartate (Fig. 6F, sequence
alignment). We found that deﬁcient phosphorylation at the
position of the 2nd cluster (Smo1S2A2S) prevented phosphoryla-
tion at the position of the 3rd cluster (Fig. 6F, lanes 3 and 4, top
panel), whereas mimicking phosphorylation at the position of the
2nd cluster (Smo1S2D2S) promoted phosphorylation at the position
of the 3rd cluster (lane 7, top panel). However, phosphorylation at
the position of the 2nd cluster (Smo2S2D3S) did not promote
phosphorylation at the position of the 1st cluster (lane 9 com-
pared to lane 3, top panel) and did not affect Hh-induced
phosphorylation at the 1st cluster (lane 10 compared to lane 4,
top panel). Taken together, these data suggest that phosphoryla-
tion at proximal clusters promotes phosphorylation of the distal
cluster, and that phosphorylation at a proximal cluster is not
inﬂuenced by phosphorylation at the distal cluster.
Both PKA and CK1 phosphorylation are regulated by Hh
To examine the contribution of PKA or CK1 phosphorylation to
Smo activity, we constructed Myc-SmoAPKADDCK1, in which the
PKA sites were mutated to alanine and CK1 sites were mutated to
aspartate in the three clusters (Fig. 4A). SmoAPKADDCK1 and
SmoDDD induced comparable levels of ectopic dpp-lacZ expression
(Fig. 4M, compared to C), which was most likely due to the higher
level of cell surface accumulation (Fig. 4S) and suggests that CK1
phosphorylation plays a potent role in Smo activation. We further
found that a phosphomimetic mutation at one PKA or CK1 site
(SmoAPKADACK1 and SmoDPKAAACK1, Fig. 4A) did not affect theactivity of Smo (Fig. 4N–O, compared to SmoWT, 4B). These results
suggest that phosphorylation leads to Smo activation in a dose-
dependent manner.
We next determined if SmoAPKADDCK1 and SmoDDD had equal
activity. We found that SmoAPKADDCK1 induced less ptc-lacZ and
en expression in A compartment cells of the wing disc (Fig. 4Q and
Q0, compared to Fig. 4P and P0), suggesting that PKA phosphoryla-
tion of Smo contributes to Smo activation in addition to its
priming role. Consistently, SmoDPKAAACK1 transduced low levels
Hh signaling activity by restoring dpp-lacZ expression, but not
high levels Hh signaling activity because it did not rescue ptc and
en expression in smo mutant cells near the A/P boundary (Fig. 4A,
data not shown).
PKA phosphorylation primes CK1 phosphorylation at adjacent
sites in the phosphorylation clusters. However, it is not known
whether PKA phosphorylation constitutively promotes CK1 phos-
phorylation or whether CK1 phosphorylation is regulated by Hh.
To address these questions, we carried out experiments with S2
cells to examine Smo phosphorylation at the three clusters of CK1
sites. We generated Smo222ASS and Smo222DSS in which PKA sites
were mutated to either alanine to block PKA phosphorylation or
aspartate to mimic PKA phosphorylation, respectively, in the
background of Smo222. This approach allowed for the detection
of Smo phosphorylation at the positions of three clusters that had
higher afﬁnity for the anti-SmoP antibody (Fig. 6G, sequence
alignment). Consistently, we found that Hh induced phosphoryla-
tion at clusters of PKA and CK1 sites (Fig. 6G, lanes 1–2, top
panel), since the anti-SmoP antibody was able to detect both PKA
and CK1 phosphorylation (Fig. 1). We further found that a
phosphomimetic mutation at the PKA sites (Smo222DSS) induced
lightly higher CK1 phosphorylation at adjacent sites when Hh was
absent (Fig. 6G, lane 5 compared to lane 1, top panel), but induced
CK1 hyperphosphorylation when Hh was present (lane 6, top
panel), suggesting that CK1 phosphorylation is regulated by Hh.
Smo222ASS was not phosphorylated either in the presence or
absence of Hh (Fig. 6G, lanes 3–4, top panel), indicating that
CK1 phosphorylation requires phosphorylation at the adjacent
PKA sites. In addition, the inactivation of CK1 by the CK1–7
inhibitor blocked the phosphorylation of Smo222DSS, indicating
that the phosphorylation was indeed mediated by CK1 (lane 7, top
panel).
Phosphorylation at the PKA/CK1 clusters of Smo promotes
Cos2 interaction with Smo C-tail
Previous studies have shown that Cos2 binds two distinct
domains in the Smo C-terminal tail: one located next to the 7th
transmembrane domain and the other in the C-terminus (Jia et al.,
2003; Lum et al., 2003). To test whether phosphorylation of Smo
at the three clusters promotes the interaction between Smo
C-terminus and Cos2, we co-transfected S2 cells with Myc-tagged
Smo variants and HA-tagged Cos2 (HA-Cos2) and performed an
immunoprecipitation assay to detect the interaction between
Smo and Cos2. We found that Smo-Cos2 interaction was
enhanced by Hh treatment (Fig. 7A, lanes 1 and 2, top panel)
and that the Smo phosphomimetic mutation (SmoDDD) strongly
interacted with Cos2 compared to SmoWT (Fig. 7A, lanes 3 and 4,
top panel). These results were consistent with the ﬁnding that
phosphomimetic Smo mutations increased the FRET with Cos2
(Shi et al., 2011). We further found that SmoDDA had a very weak
interaction with Cos2 even in the presence of Hh (Fig. 7A, lanes
5 and 6, top panel), suggesting that a phospho-deﬁcient mutation
at the third cluster of Smo prevents its interaction with Cos2.
Our ﬁndings that SmoDDA had very low efﬁciency of FRET at its
C-terminus (Fig. 4T), and that SmoDDA had very low signaling
activity in vivo (Fig. 4L), suggest that phosphorylation of Smo at
Fig. 7. Mechanisms of Smo phosphorylation and dimerization at the C-terminus.
(A) S2 cells were co-transfected with HA-Cos2 and Smo variants. Immunoprecipi-
tation was carried out with anti-Myc antibody followed by western blot with anti-
Myc to detect the expression of Smo and anti-HA antibody to detect the bound
Cos2. Myc-Smo was normalized by the method described above. Cell lysates were
also subjected to direct western blot with the anti-HA antibody to examine the
expression of Cos2. (B–D) A model of Smo differential phosphorylation that
mediates thresholds of Hh signaling activity: Gene expression pattern in response
to Hh activity gradient (B); Increasing Hh activity elevates the levels of Smo
phosphorylation (C); Gradient Hh activity signal transduction by differential Smo
phosphorylation (D). (E) A zipper-lock model demonstrates the intra-molecular
mechanism of the Smo conformational change that is regulated by Hh. Dimeriza-
tion of the Smo C-terminal tail promotes Cos2 binding.
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at its C-terminus, which is responsible for the Hh-induced inter-
action between Smo and Cos2.
Taken together, these data provide direct evidence that an Hh
activity gradient induces differential phosphorylation of Smo,
which consequently induces different levels of Hh target gene
expression (Fig. 7B–D). Furthermore, we demonstrated that Hh
regulates the intra-molecular changes of Smo, which mediates
differential Smo cell surface accumulation, dimerization, and
activation (Fig. 7E).Discussion
Smo is a major therapeutic target since it plays a central role in
the Hh signaling pathway, and abnormal Smo activation has been
shown to play a direct role in basal cell carcinoma and medullo-
blastoma (Jiang and Hui, 2008). Therefore, understanding the
molecular mechanisms underlying Smo activation is currently of
great interest in the ﬁeld. In this study, we show that different
levels of Hh signaling activity induce distinct levels of Smo
phosphorylation, which promote different levels of Smo cell
surface accumulation. By using a phospho-speciﬁc antibody, we
were able to precisely correlate the levels of signaling activity
with the levels of Smo phosphorylation. By carrying out a series of
mutagenesis analyses within three phosphorylation clusters, we
found that Smo phosphorylation has a positional effect in reg-
ulating its activity. Phosphorylation at the ﬁrst cluster is more
critical for triggering Smo activation. In addition, we demon-
strated that a phospho-deﬁcient mutation in the third cluster
severely blocks dimerization of the C-terminal tail. Therefore, we
have provided evidence that thresholds of Hh activity promote
differential Smo phosphorylation, which mediates a zipper-lock-
like gradual dimerization through three phosphorylation clusters.
Since vertebrate Smo is phosphorylated in response to Shh (Chen
et al., 2011), the mechanism that we have uncovered here is likely
to be conserved in other species.
The contribution of differential phosphorylation to Smo activation
It has been previously shown that Smo is hyperphosphorylated
by multiple kinases in response to Hh stimulation (Apionishev
et al., 2005; Chen et al., 2010; Jia et al., 2010, 2004; Zhang et al.,
2004). Among these kinases, PKA and CK1 are bona ﬁde Smo
kinases that are essential and responsible for the initiation of Smo
phosphorylation by other kinases. Several lines of evidence
support this model. First, Smo phosphorylation by PKA and CK1
promotes phosphorylation by GRK2 (Chen et al., 2010). Second,
SmoDDD, which is a mutant that contains phosphomimetic muta-
tions at the three clusters, induces the peak level of Hh signaling
activity (Jia et al., 2004). Third, using a phospho-speciﬁc antibody
to detect phosphorylation at the 2nd cluster, we demonstrated
that Hh promotes differential phosphorylation of Smo at these
clusters, which solely dictates the thresholds of Hh activity. Our
ﬁndings suggest that a higher stoichiometry of Smo phosphoryla-
tion at PKA and CK1 sites promotes higher levels of inter-
molecular dimerization/oligomerization, and as a result enhances
the downstream signaling. It will be interesting to determine the
contribution of phosphorylation at other residues, which are not
PKA and CK1 sites, to the stoichiometric Smo phosphorylation, as
it has been shown that Hh induces phosphorylation at 26 residues
located in the Smo C-terminal tail (Zhang et al., 2004). It will be
also interesting to examine whether differential phosphorylation
of Cos2 (Ranieri et al., 2012) correlates with the differential
phosphorylation of Smo.
The regulation of Hh-induced phosphorylation of Smo
In this study, we showed that Hh regulates Smo not only at the
inter-molecular but also intra-molecular level. We provide evi-
dence that multiple phosphorylation motifs (clusters) function
cooperatively to transduce the Hh signal. Progressive inactivation
of these phosphorylation motifs by phospho-deﬁcient mutations
incrementally reduces the ability of Smo to promote Hh signaling,
whereas activation of these motifs by phosphomimetic mutations
enhances this ability. However, a phospho-deﬁcient mutation at a
single PKA site among the three clusters (SmoASS, SmoSAS, and
SmoSSA in this study; and SmoPKA1, SmoPKA2, and Smo-PKA3 in
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of Smo to transduce the Hh signal (this study) (Jia et al., 2004).
Smo may employ a ‘‘self-correction’’ mechanism in which phos-
phorylation at one PKA/CK1 cluster counteracts the deﬁciency of
phosphorylation at the other PKA/CK1 cluster(s). In support
of this hypothesis, a phosphomimetic mutation in the background
of S4A mutations (SmoADA and SmoDAA) attenuated the domi-
nant-negative activity of these double mutants (Figs. 5D and E, F
and G). It is also possible that phosphorylation at sites outside the
three PKA/CK1 clusters could compensate for the reduction in
PKA/CK1 phosphorylation at the three clusters.
In this study, we carefully examined the contribution of PKA
and CK1 phosphorylation to Smo activation by assessing a series
of site mutations. We show that PKA activates Smo by both
phosphorylating Smo and priming CK1 phosphorylation of Smo.
We found that SmoDPKAAACK1 has a low level of signaling activity
by restoring dpp-lacZ expression in smo mutant cells, and that
Smo APKADDCK1 has lower signaling activity compared to SmoDDD
(summarized in Fig. 4A). These observations are consistent with
the model in which low levels of Hh induce PKA site phosphor-
ylation, and high levels of Hh induce further phosphorylation by
CK1 (Su et al., 2011).
It remains unclear how Hh regulates Smo phosphorylation.
It is unlikely that Hh induces Smo phosphorylation by increasing
cAMP-dependent PKA activity. For instance, expressing the cAMP-
independent PKA catalytic subunit (MCn) in wing discs only
caused an anterior expansion of Smo accumulation near the A/P
boundary, but did not cause Smo accumulation in A compartment
cells away from the A/P boundary where Hh was absent (Jia et al.,
2004; Liu et al., 2007). In addition, MCn can substitute for
endogenous PKA to confer normal regulation of the Hh pathway
(Jiang and Struhl, 1995; Ohlmeyer and Kalderon, 1997), suggest-
ing that Hh does not regulate PKA activity per se. However, it is
possible that Hh regulates the accessibility of kinases or the
phosphatase(s) to Smo, which consequently promotes the hyper-
phosphorylation of Smo.Experimental procedures
Constructs, mutants, and transgenes
The creation of the attB-UAST-Myc-SmoWT construct and the
generation of transgenes at 75B1 attP locus (resulting VK5 lines)
by PhiC31 integration have been previously described (Jia et al.,
2009). Smo variants with mutations in the PKA and CK1 sites
were generated by site-directed mutagenesis and their transgenes
were generated at the 75B1 attP locus, resulting in a series of VK5
lines. Some of the Smo mutants were swapped from constructs
generated from our previous studies (Jia et al., 2010, 2004). The
approach of making tub-Smo222 and UAS-Myc-Smo222 was similar
to that of making tub-SmoWT previously described (Jia et al.,
2010). All of the Smo rescue constructs in combination with the
tubulina promoter were generated using the same approach and
the corresponding VK5 lines were generated. The genotypes for
generating smo clones were as follows: smo clones expressing
VK5-Smo variants by the tubulina promoter, yw hsp-ﬂp/þor
Y; smo3 FRT40/hs-GFP FRT40; UAS-VK5-tub-Smo variants; or by
the MS1096-Gal4, yw hsp-ﬂp, MS1096/þor Y; smo3 FRT40/hs-GFP
FRT40; UAS-VK5-Myc-Smo variants. GST-SmoPKA and GST-
SmoCK1 containing Smo aa656-755 with either the single PKA
site or the two CK1 sites in the 2nd cluster mutated to alanine.
The tub-Ci construct was created by replacing the UAS binding
sites in pUAST with the tubulina promoter and then subsequently
fusing the 2HA-Ci cDNA afterward. HA-Cos2 has been previously
described (Liu et al., 2007), and ﬂies of C765-Gal4, MS1096 Gal4,and ap-Gal4 have been previously described (Flybase) (Jia et al.,
2010; Liu et al., 2007).
Anti-SmoP antibody production
The anti-SmoP antibody was generated by Genemed Synthesis Inc.
by injecting the antigen peptide CRHVSVESRRN(pS)VD(pS)QV(pS)VK
into rabbits. The serumwas afﬁnity-puriﬁed with the antigen and the
ﬂowthrough was kept as a control antibody against non-phosphory-
lated peptide.
In vitro kinase assay
For the in vitro kinase assay, GST-Smo fusion proteins were
expressed in bacteria, puriﬁed with standard protocols, and
subjected to a kinase assay with commercial PKA and CK1 (New
England Biolabs) according to the supplier0s protocols. Phosphory-
lated proteins were then analyzed by western blot with either
anti-GST or anti-SmoP antibodies.
Cell culture, transfection, immunoprecipitation, western blot, and
luciferase reporter assay
S2 cells were cultured as previously described (Liu et al., 2007).
The transfection was carried out using Effectene transfection reagent
(Qiagen). The immunoprecipitation and immunoblot analysis were
performed using a standard protocol. The use of HhN-conditioned
medium has been previously described (Liu et al., 2007). Treating S2
cells with H-89 and CK1–7 inhibitors has also been previously
described (Jia et al., 2004). The method of using MG132 (Calbiochem),
a proteasome inhibitor, and NH4Cl (Sigma-Aldrich), a lysosome
inhibitor, to block Smo degradation has been previously described
(Li et al., 2012; Xia et al., 2012). Antibodies used in this study were as
follows: mouse anti-Myc (9E10, Santa Cruz, 1:5000), anti-Flag (M2,
Sigma, 1:10000), anti-HA (F7, Santa Cruz, 1:1500), anti-GFP (Milli-
pore, 1:1000); rabbit anti-SmoP (this study, 1:50), anti-PKA (Santa
Cruz, 1:5000), and anti-GST (Santa Cruz, 1:10000). For ptc-luciferase
reporter assays, S2 cells were cultured in 6-well plates and trans-
fected with 50 ng tub-Ci and 150 ng ptc-luciferase reporter constructs
with or without Smo variant constructs. After 48 h post-transfection,
the cells were lysed for luciferase activity analysis using the Dual-
Luciferase Reporter Assay System (Promega, Madison, WI, USA).
Renilla was used to normalize the luciferase activity. The measure-
ments of Dual-Luciferase were performed using a GLOMAX Multi
Detection System (Promega). A representative assay of three is shown
and error bars indicate standard deviation (S.D.) from four repeats.
Cell surface staining and FRET analysis using confocal microscopy
The cell-based assay to detect Smo cell surface accumulation
was carried out by immunostaining with the anti-SmoN antibody
before cell permeabilization (Jia et al., 2004). For FRET analysis,
S2 cells transfected with Smo constructs tagged with CFP or YFP
at the C-terminus were treated with HhN-conditioned medium or
control medium. For maximal Hh signal strength, a UAST-Hh
construct was also included in the transfection. Cells were then
washed with PBS, ﬁxed with 4% formaldehyde for 20 min, and
mounted on slides in 80% glycerol. Fluorescence signals were
acquired with the 60 x objective on an Olympus confocal micro-
scope. CFP was excited at 458nm wavelength and the emission
was collected through a BA 480–495 nm ﬁlter. YFP was excited at
514 nm wavelength and the emission was collected through a BA
535–565 nm ﬁlter. The CFP signal was obtained once before (BP)
and once after (AP) photobleaching YFP using the full power of
the 515 nm laser line for 2–3 min at the top half of each
cell, leaving the bottom half of the cell as an internal control.
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Fluoview software. The efﬁciency of FRET was calculated using
the formula: FRET%¼[(CFPAPCFPBP)/CFPAP]100%. Each data
set was based on 15 individual cells. In each cell, ﬁve regions of
interest in the photobleached area were selected for analysis.
Immunostaining of wing imaginal discs
A standard protocol was used for the wing disc immunostaining
assay. Antibodies used in this study were as follows: mouse anti-
Myc (9E10, Santa Cruz, 1:50), anti-Flag (M2, Sigma, 1:150), anti-
SmoN (DSHB, 1:10), anti-Ptc (DSHB, 1:10), anti-En (DSHB, 1:20);
rabbit anti-SmoP (this study, 1:10), anti-b-Gal (Cappel, 1:1500),
anti-GFP (Clontech, 1:500), anti-PKA (Santa Cruz, 1:150); and rat
anti-Ci, 2A1 (Motzny and Holmgren, 1995).Acknowledgments
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